Share on StockTwits
 

GW Pharmaceuticals Plc – American Depositary Shares (NASDAQ:GWPH) set a new 52-week high during mid-day trading on Thursday, ARN reports. The stock traded as high as $55.09 and last traded at $54.64, with a volume of 153,093 shares. The stock had previously closed at $51.53.

Several analysts have recently commented on the stock. Analysts at Piper Jaffray initiated coverage on shares of GW Pharmaceuticals Plc – American Depositary Shares in a research note to investors on Tuesday, November 26th. They set an “overweight” rating and a $73.00 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of GW Pharmaceuticals Plc – American Depositary Shares from $39.00 to $41.00 in a research note to investors on Wednesday, November 20th. They now have a “buy” rating on the stock. Finally, analysts at Cowen and Company raised their price target on shares of GW Pharmaceuticals Plc – American Depositary Shares from $33.00 to $40.00 in a research note to investors on Friday, November 15th. Five equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus price target of $43.00.

GW Pharmaceuticals Plc – American Depositary Shares has a 52-week low of $8.46 and a 52-week high of $52.40. The stock’s 50-day moving average is $41.72 and its 200-day moving average is $25.85. The company’s market cap is $933.1 million.

GW Pharmaceuticals Plc – American Depositary Shares (NASDAQ:GWPH) last released its earnings data on Tuesday, November 19th. The company reported ($0.29) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.10. On average, analysts predict that GW Pharmaceuticals Plc – American Depositary Shares will post $-1.60 earnings per share for the current fiscal year.

GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the research, development and commercialization of a range of cannabinoid prescription medicines to meet patient needs in a range of medical conditions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.